Literature DB >> 10979287

[Obstructive sleep apnea syndrome in a patient with superior vena cava syndrome caused by lung cancer].

M Ito1, J Tanaka, K Kubota, H Sato, M Takahashi, H Tanaka, T Ohdaira, H Yoshizawa, Y Muramatsu, M Satoh, E Suzuki, M Arakawa, F Gejyo.   

Abstract

A 48-year-old man was treated with chemotherapy and irradiation therapy for superior vena cava syndrome (SVCS) caused by adenocarcinoma of the lung, and his symptoms subsided temporarily. However, the same symptoms recurred, and severe snoring during sleep and daytime hypersomnolence developed. Obstructive sleep apnea syndrome (OSAS) was diagnosed by respiratory inductive plethysmography. After chemotherapy, the symptoms of edema of the face and arms, snoring, and daytime somnolence tendency were alleviated, and the patient's apnea hypopnea index decreased remarkably. In addition, lateral cephalograms disclosed improved patency of the upper respiratory tract and dilation of the soft palate. These findings suggested a relationship between SVCS and OSAS. OSAS may cause a deterioration of circulatory dynamics and the quality of life when it develops secondary to SVCS. Therefore, it is necessary to determine whether OSAS is present and accordingly provide suitable treatment in patients with SVCS.

Entities:  

Mesh:

Year:  2000        PMID: 10979287

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  2 in total

1.  Worsening of Obstructive Sleep Apnea Associated with Catheter-Related Superior Vena Cava Syndrome.

Authors:  Marie Jouvenot; Serge Willoteaux; Nicole Meslier; Frédéric Gagnadoux
Journal:  J Clin Sleep Med       Date:  2015-06-15       Impact factor: 4.062

2.  Coexistence of Obstructive Sleep Apnea and Superior Vena Cava Syndromes Due to Substernal Goitre in a Patient With Respiratory Failure: A Case Report.

Authors:  Mehtap Tunc; Hilal Sazak; Bulent Karlilar; Fatma Ulus; Irfan Tastepe
Journal:  Iran Red Crescent Med J       Date:  2015-05-31       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.